Agenus Reports Three-Year Phase 1b Results for Botensilimab Plus Balstilimab Showing Durable Survival in Refractory MSS Metastatic Colorectal Cancer Agenus Inc., a biotechnology company focused on advancing next-generation immuno-oncology therapies, has announced encouraging three-year follow-up results from its fully enrolled…
bioAffinity Technologies Reports More Than 200% Growth in CyPath® Lung Sales as Physician Adoption Continues to Accelerate bioAffinity Technologies, Inc., a biotechnology company dedicated to developing innovative, noninvasive diagnostic solutions for lung cancer and other pulmonary diseases, has announced strong…
Orion and Shilpa Medicare Expand European Nivolumab Biosimilar Partnership Shilpa Medicare Limited has announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and long-term supply agreement with Orion Corporation for the development and commercialization…
Elucid to Showcase Next-Generation AI-Powered Coronary CT Technologies and Advance Its CCTA 3.0 Vision at SCCT 2026 Elucid, a medical technology company specializing in artificial intelligence-powered coronary CT angiography (CCTA) analysis, has announced its largest and most comprehensive participation to…
AGC Pharma Chemicals Validates New Barcelona CDMO Facility Through Scientist.com’s VERIF.i® Supplier Assessment Program AGC Pharma Chemicals, a leading global Contract Development and Manufacturing Organization (CDMO) specializing in small molecule active pharmaceutical ingredients (APIs) and highly potent active pharmaceutical ingredients…
Caidya and Simbec-Orion Combine to Create Global Specialty CRO Platform Spanning Early-Phase Research Through Late-Stage Clinical Development Caidya has announced a strategic combination with Simbec-Orion, marking a significant step in the evolution of both organizations as they seek to deliver…
FNIH and Leading Advocates Launch Music as Medicine Neuroscience Initiative The Foundation for the National Institutes of Health (FNIH) has announced the launch of the Music as Medicine Neuroscience Research Initiative, a new program designed to accelerate scientific research into…
Croma-Pharma Secures FDA Approval for Obagi saypha® ChIQ™ to Expand Facial Aesthetic Treatment Options in the U.S. Croma-Pharma has reached another significant milestone in its global growth strategy with the U.S. Food and Drug Administration (FDA) approving Obagi saypha® ChIQ™,…
Caidya and Simbec-Orion Unite to Create Global Specialty CRO for End-to-End Drug Development Caidya has announced a strategic combination with Simbec-Orion, marking a significant milestone in the clinical research industry by creating a global specialty contract research organization (CRO) designed…
Feinstein Institutes Uncover Ancient Reflex Linked to Future Brain Injury Therapies Researchers at Northwell Health’s Feinstein Institutes for Medical Research have uncovered the molecular mechanism behind one of the body’s oldest survival responses—the diving reflex—providing new insights that could transform…
Incyte Receives Positive CHMP Opinion for Opzelura® Cream in Adults with Moderate Atopic Dermatitis Incyte has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the…
Elevation Spine Surpasses 5,000 Saber-C Implantations, Highlighting Growing Adoption of Its Integrated Cervical Fusion Technology Elevation Spine has announced a significant milestone for its cervical spine portfolio, revealing that more than 5,000 Saber-C Anterior Cervical Fusion System implantations have now…